{
  "symbol": "REGN",
  "data_type": "company_profile",
  "timestamp": "2025-09-19T14:50:00.595362",
  "data": {
    "address": "777 Old Saw Mill River Road",
    "alias": null,
    "city": "Tarrytown",
    "country": "US",
    "currency": "USD",
    "cusip": "75886F107",
    "description": "Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. The company is headquartered in Tarrytown, New York and currently employs 15,106 full-time employees.  The firm invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The firm is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.",
    "employeeTotal": 15106,
    "estimateCurrency": "USD",
    "exchange": "NASDAQ NMS - GLOBAL MARKET",
    "finnhubIndustry": "Biotechnology",
    "floatingShare": 102.06,
    "fundamentalFreq": "q",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Biotechnology",
    "gsector": "Health Care",
    "gsubind": "Biotechnology",
    "insiderOwnership": 1.8582,
    "institutionOwnership": 91.9062,
    "ipo": "1991-04-02",
    "irUrl": "https://investor.regeneron.com/",
    "isin": "US75886F1075",
    "lei": "549300RCBFWIRX3HYQ56",
    "logo": "https://static2.finnhub.io/file/publicdatany/finnhubimage/stock_logo/REGN.svg",
    "marketCapCurrency": "USD",
    "marketCapitalization": 63455.741229052175,
    "marketcapUSD": 0,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Pharmaceutical Preparation Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Regeneron Pharmaceuticals Inc",
    "phone": "17813705000",
    "sedol": "2730190",
    "shareOutstanding": 105.99,
    "state": "NEW YORK",
    "ticker": "REGN",
    "usShare": 0,
    "weburl": "https://www.regeneron.com/"
  }
}